Rosa-Rosa, J.M.; Cuenca, I.; Medina, A.; Vázquez, I.; Sánchez-delaCruz, A.; Buenache, N.; Sánchez, R.; Jiménez, C.; Rosiñol, L.; Gutiérrez, N.C.;
et al. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 2022, 14, 5169.
https://doi.org/10.3390/cancers14205169
AMA Style
Rosa-Rosa JM, Cuenca I, Medina A, Vázquez I, Sánchez-delaCruz A, Buenache N, Sánchez R, Jiménez C, Rosiñol L, Gutiérrez NC,
et al. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers. 2022; 14(20):5169.
https://doi.org/10.3390/cancers14205169
Chicago/Turabian Style
Rosa-Rosa, Juan Manuel, Isabel Cuenca, Alejandro Medina, Iria Vázquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sánchez, Cristina Jiménez, Laura Rosiñol, Norma C. Gutiérrez,
and et al. 2022. "NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial" Cancers 14, no. 20: 5169.
https://doi.org/10.3390/cancers14205169
APA Style
Rosa-Rosa, J. M., Cuenca, I., Medina, A., Vázquez, I., Sánchez-delaCruz, A., Buenache, N., Sánchez, R., Jiménez, C., Rosiñol, L., Gutiérrez, N. C., Ruiz-Heredia, Y., Barrio, S., Oriol, A., Martin-Ramos, M. -L., Blanchard, M. -J., Ayala, R., RÃos-Tamayo, R., Sureda, A., Hernández, M. -T.,
... MartÃnez-Lopez, J.
(2022). NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers, 14(20), 5169.
https://doi.org/10.3390/cancers14205169